 |
|
Onset of Major Depression Associated With Acute Coronary Syndromes
Relationship of Onset, Major Depressive Disorder History, and Episode Severity to Sertraline Benefit
Alexander H. Glassman, MD;
J. Thomas Bigger, MD;
Michael Gaffney, PhD;
Peter A. Shapiro, MD;
J. Robert Swenson, MD
Arch Gen Psychiatry. 2006;63:283-288.
Context Depression observed following acute coronary syndrome (ACS) is common and associated with an increased risk of death. The Sertraline Antidepressant Heart Attack Trial (SADHART) tested the safety and efficacy of a selective serotonin reuptake inhibitor in this population. No evidence of harm was seen, and sertraline hydrochloride had an overall beneficial effect on mood that occurred primarily in patients with a history of episodes of major depressive disorder (MDD).
Objectives To determine how frequently the MDD began before ACS and whether onset of the current MDD episode before or after the ACS event influenced response to sertraline.
Design, Settings, and Participants A randomized, double-blind, placebo-controlled treatment of 369 patients with ACS and MDD was conducted in 40 outpatient clinics in 10 countries between April 1, 1997, and April 30, 2001.
Main Outcome Measures Diagnosis of MDD, number of previous episodes of depression, and episode onset before or after hospitalization were established using the Diagnostic Interview Schedule. Treatment response was measured with the Clinical Global Impression–Improvement scale.
Results Fifty-three percent of MDD episodes began before hospitalization for the index episode of ACS (for 197 of 369 patients), and 94% of the MDD episodes began more than 30 days before the index ACS episode. Episodes of MDD that began prior to ACS responded more frequently to sertraline than to placebo (63% vs 46%, respectively; odds ratio, 2.0; 95% confidence interval, 1.13-3.55) whereas depression with onset beginning after hospitalization showed a high placebo response rate (69% vs 60%, respectively) and low sertraline-placebo response ratio (1.15). Multivariate analysis indicated that time of onset of the current episode, history of MDD, and baseline severity independently predicted the sertraline-placebo response ratio.
Conclusions Half of the episodes of major depression associated with ACS began long before ACS and therefore were not caused by ACS. Patients whose current episodes of MDD begin before ACS, those with a history of MDD, and those whose episodes are severe should be treated because they will benefit considerably from sertraline. Since these 3 predictors of sertraline response are independent, having more than 1 of them substantially increases the benefit of sertraline while reducing the chance of spontaneous recovery.
Author Affiliations: Departments of Psychiatry (Drs Glassman and Shapiro) and Medicine (Dr Bigger), College of Physicians and Surgeons, Columbia University, New York, NY; Pfizer, Inc, New York (Dr Gaffney); and Department of Psychiatry, University of Ottawa, Ottawa, Ontario (Dr Swenson).
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Inflammation and its relevance to psychiatry
Cavanagh and Mathias
Adv. Psychiatr. Treat. 2008;14:248-255.
ABSTRACT
| FULL TEXT
Pre-existent depression in the 2 weeks before an acute coronary syndrome can be associated with delayed presentation of the heart attack
Wong et al.
QJM 2008;101:137-144.
ABSTRACT
| FULL TEXT
Nonresponse to Treatment for Depression Following Myocardial Infarction: Association With Subsequent Cardiac Events
de Jonge et al.
Am. J. Psychiatry 2007;164:1371-1378.
ABSTRACT
| FULL TEXT
Heart Rate Variability in Acute Coronary Syndrome Patients With Major Depression: Influence of Sertraline and Mood Improvement
Glassman et al.
Arch Gen Psychiatry 2007;64:1025-1031.
ABSTRACT
| FULL TEXT
Significant and increasing depressive symptoms are associated with increased risk of new cardiac events in people with a heart attack in the previous year
Huffman
Evid. Based Ment. Health 2007;10:42-42.
FULL TEXT
Effects of Citalopram and Interpersonal Psychotherapy on Depression in Patients With Coronary Artery Disease: The Canadian Cardiac Randomized Evaluation of Antidepressant and Psychotherapy Efficacy (CREATE) Trial
Lesperance et al.
JAMA 2007;297:367-379.
ABSTRACT
| FULL TEXT
Antidepressants in Coronary Heart Disease: SSRIs Reduce Depression, But Do They Save Lives?
Glassman and Bigger
JAMA 2007;297:411-412.
FULL TEXT
Depression After Myocardial Infarction: Unraveling the Mystery of Poor Cardiovascular Prognosis and Role of Beta-Blocker Therapy
von Kanel and Begre
J Am Coll Cardiol 2006;48:2215-2217.
FULL TEXT
|
